These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35729539)

  • 1. Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea.
    Marin-Oto M; Sanz-Rubio D; Santamaría-Martos F; Benitez I; Simon AL; Forner M; Cubero P; Gil A; Sanchez-de-laTorre M; Barbe F; Marin JM
    Respir Res; 2022 Jun; 23(1):163. PubMed ID: 35729539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble receptor for advanced glycation end-products and progression of airway disease.
    Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
    BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome.
    Kuklisova Z; Tkacova R; Joppa P; Wouters E; Sastry M
    Sleep Med; 2017 Feb; 30():139-145. PubMed ID: 28215237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.
    Marin JM; Soriano JB; Carrizo SJ; Boldova A; Celli BR
    Am J Respir Crit Care Med; 2010 Aug; 182(3):325-31. PubMed ID: 20378728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleepiness, fatigue, anxiety and depression in Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea - Overlap - Syndrome, before and after continuous positive airways pressure therapy.
    Economou NT; Ilias I; Velentza L; Papachatzakis Y; Zarogoulidis P; Kallianos A; Trakada G
    PLoS One; 2018; 13(6):e0197342. PubMed ID: 29889828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria in Patients with Obstructive Sleep Apnea-Chronic Obstructive Pulmonary Disease Overlap Syndrome.
    Matsumoto T; Murase K; Tachikawa R; Minami T; Hamada S; Tanizawa K; Inouchi M; Handa T; Oga T; Yanagita M; Mishima M; Chin K
    Ann Am Thorac Soc; 2016 Jun; 13(6):917-25. PubMed ID: 26966922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the prevalence, pathogenesis and management of OSA-COPD overlap.
    Brennan M; McDonnell MJ; Walsh SM; Gargoum F; Rutherford R
    Sleep Breath; 2022 Dec; 26(4):1551-1560. PubMed ID: 35034250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of benefit of continuous positive airway pressure on lung function in patients with overlap syndrome.
    O'Brien A; Whitman K
    Lung; 2005; 183(6):389-404. PubMed ID: 16465599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peripheral neutrophils in subjects with COPD-OSA overlap syndrome and severe comorbidities: A feasible inflammatory biomarker?
    Macrea M; Campbell S; Martin T; Oursler KA
    Adv Clin Exp Med; 2018 Dec; 27(12):1677-1682. PubMed ID: 30085419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
    Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
    Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome.
    Stanchina ML; Welicky LM; Donat W; Lee D; Corrao W; Malhotra A
    J Clin Sleep Med; 2013 Aug; 9(8):767-72. PubMed ID: 23946706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for COPD exacerbations and mortality in patients with overlap syndrome.
    Jaoude P; El-Solh AA
    Clin Respir J; 2019 Oct; 13(10):643-651. PubMed ID: 31436034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Predictors of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease Undergoing Inpatient Pulmonary Rehabilitation.
    Schreiber A; Cemmi F; Ambrosino N; Ceriana P; Lastoria C; Carlucci A
    COPD; 2018 Jun; 15(3):265-270. PubMed ID: 30239226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea.
    Wang TY; Lo YL; Lee KY; Liu WT; Lin SM; Lin TY; Ni YL; Wang CY; Ho SC; Kuo HP
    Respir Res; 2013 Jun; 14(1):66. PubMed ID: 23782492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry.
    Adler D; Bailly S; Soccal PM; Janssens JP; Sapène M; Grillet Y; Stach B; Tamisier R; Pépin JL
    PLoS One; 2021; 16(8):e0256230. PubMed ID: 34383866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive sleep apnea exacerbates airway inflammation in patients with chronic obstructive pulmonary disease.
    Wang Y; Hu K; Liu K; Li Z; Yang J; Dong Y; Nie M; Chen J; Ruan Y; Kang J
    Sleep Med; 2015 Sep; 16(9):1123-30. PubMed ID: 26298789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous positive airway pressure and isocapnic-hypoxia on cerebral autoregulation in patients with obstructive sleep apnoea.
    Waltz X; Beaudin AE; Hanly PJ; Mitsis GD; Poulin MJ
    J Physiol; 2016 Dec; 594(23):7089-7104. PubMed ID: 27644162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
    Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
    Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
    Malik P; Hoidal JR; Mukherjee TK
    COPD; 2021 Dec; 18(6):737-748. PubMed ID: 34615424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure.
    Westhoff M; Arzt M; Litterst P
    Sleep Breath; 2012 Mar; 16(1):71-8. PubMed ID: 21347650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.